News

CooperCompanies Reports Strong Q3 Financial Performance

CooperCompanies Reports Strong Q3 Financial Performance

CooperCompanies Reports Third Quarter 2025 Financial Highlights

CooperCompanies (COO), a prominent name in the global medical device sector, has recently unveiled its financial outcomes for the third quarter of its fiscal year, which concluded on the last day of July 2025. This announcement is generating significant interest among investors and analysts alike.

Revenue Growth Insights

The company's revenue witnessed an impressive year-over-year increase of 6%, reaching a total of $1,060.3 million for this quarter. Breaking down the revenue streams, CooperVision (CVI) contributed $718.4 million, also marking a 6% rise compared to the previous year. Meanwhile, CooperSurgical (CSI) generated $341.9 million, reflecting a 4% growth in its sales.

Key Earnings Metrics

  • GAAP diluted earnings per share (EPS) came in at $0.49, a minor decline from the previous year's comparable quarter, while non-GAAP diluted EPS rose to $1.10, up by 15% year-over-year.
  • This signifies a robust operational performance that the company attributes to its strategic initiatives and efficiency improvements.

Operational Performance Overview

CooperCompanies' President and CEO, Al White, expressed satisfaction with their operational performance, highlighting not only the margins but also the double-digit growth in earnings. He mentioned that while revenues fell slightly short of expectations, the company’s operational excellence reflects favorably on their growth strategy. Additionally, guidance for earnings has been raised due to strong performance in operations.

CooperVision Contributions and Breakdown

CooperVision’s performance during the quarter included a significant organic growth despite fluctuations in currency. The brand’s focus on innovation continues to yield positive results, thereby enhancing its market position. Particularly, the introduction of their MyDAY® product line is expected to drive revenue growth in the upcoming quarters.

Geographical Revenue Performance

The revenue was also analyzed by geographical segments, indicating solid performance across all key markets:

  • Americas: $286.0 million, marked by a 2% organic growth.
  • EMEA: Revenue from this region reached $292.1 million, benefiting from a remarkable 14% increase.
  • Asia Pacific: Generated $140.3 million, with minimal growth recorded.

Looking Ahead: Fiscal Year Guidance

The fiscal outlook for CooperCompanies remains optimistic. The company has updated its guidance for Q4 2025, expecting revenues to range between $1,049 and $1,069 million, with anticipated organic growth of 2% to 4%. For the entire fiscal year, the company forecasts total revenues to hover between $4,076 and $4,096 million, reflecting a growth strategy centered around robust operational efficiencies and market adaptability.

Additional Insights

During the quarter, CooperCompanies also engaged in share repurchase activities, purchasing approximately $52.1 million of its shares. This move demonstrates the company's commitment to returning value to its shareholders, as it continues to manage its capital efficiently.

About CooperCompanies

CooperCompanies operates through its two business units: CooperVision, which focuses on contact lenses, and CooperSurgical, specializing in fertility and women’s healthcare. With a workforce exceeding 16,000 and a presence in over 130 countries, CooperCompanies positively impacts millions of lives annually, emphasizing its role as a leader in the medical device industry.

Frequently Asked Questions

1. What were CooperCompanies' total revenues in Q3 2025?

CooperCompanies reported total revenues of $1,060.3 million for the third quarter of 2025.

2. How did CooperVision perform this quarter?

CooperVision contributed significantly, reporting revenues of $718.4 million, a 6% increase year-over-year.

3. What is the guidance for the fourth quarter?

The guidance for Q4 2025 projects revenues between $1,049 and $1,069 million, with organic growth expected to be between 2% to 4%.

4. Did the company engage in any stock repurchase programs?

Yes, CooperCompanies repurchased $52.1 million of its own stock during the third quarter.

5. What are the business segments of CooperCompanies?

CooperCompanies operates primarily through CooperVision and CooperSurgical, focusing on vision care and women's healthcare respectively.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Shareholder Votes Clear ODNB-NACB Merger's Final Hurdle

Updated Category News Views 24

A merger vote rarely makes anyone pound the table, but it does remove one very real way a bank deal can stumble. ODNB Financial Corporation and National Capital Bancorp, Inc. have announced that their shareholders approved the proposed merger. That is meaningful progress, plain and simple. It says the owners who get to live with the outcome have signed off on joining the...

Continue Reading
Siteimprove Turns Accessibility Checks Into Agent Spend

Updated Category News Views 37

Accessibility work has usually been the thing teams promise to fix after the launch party is over. Siteimprove is trying to shove that discipline directly into the AI-agent workflow, announcing on November 19, 2026 that its Siteimprove.ai Accessibility Agent is available through Agentic Commerce on AWS Marketplace. The practical hook is simple enough: an AI agent can...

Continue Reading
Würk's Bryte AI Targets Payroll's Costly Friction Points

Updated Category News Views 83

Payroll mistakes are the sort of paper cuts that suddenly turn into a hospital bill for an employer. Würk’s Nov. 19 launch of Bryte AI goes straight at that ugly reality in cannabis, beverage alcohol, and other heavily regulated workplaces, where a bad time entry, missed document, or misunderstood policy can create a far more expensive mess than ordinary office...

Continue Reading
LKQ’s Europe ERP Mess Turns Into a Credibility Test

Updated Category News Views 37

A software rollout should not be able to punch a company in the teeth twice, yet LKQ shareholders have watched precisely that ugly movie in 2026. The October 23 disclosure was a real gut-check: an immediate CEO departure, a $16 million net loss, and renewed acknowledgement that the German enterprise-resource-planning rollout was disrupting Europe. Shares fell $5.05, or...

Continue Reading
MedStar's Same-Day Test Puts Stroke Drugs on Notice

Updated Category News Views 25

A five-hour lab result can matter more than another glossy precision-medicine slogan. MedStar Health says it is using same-day genetic testing for patients with ischemic stroke, giving clinicians information before discharge that previously often arrived more than a week later. That is a practical change, not science-fiction wallpaper: a treatment decision gets made while...

Continue Reading
BreakBio's New CSO Adds Vaccine Trial Credibility in Cancer

Updated Category News Views 95

Personalized cancer vaccines have no shortage of grand promises; seasoned clinical operators are the rarer commodity. That is why BreakBio's appointment of Dr. Greg Lizée as chief scientific officer deserves a closer look, even if nobody should confuse an executive hire with clinical validation. BreakBio is private, its lead program remains in development, and cancer...

Continue Reading
JLL’s Facility Management Push Gets a Useful Nod From Frost

Updated Category News Views 123

A Building Breaks Down Long Before the Earnings Call Notices Facility management is the sort of business that gets ignored until an airport system fails, a data-center cooling unit balks, or a workforce cannot use the building it was told to return to. That is why Frost & Sullivan’s 2026 recognition of JLL deserves more than the usual award-season shrug. It points to an...

Continue Reading
Action1's 3,688% Growth Puts Patching on Investor Maps

Updated Category News Views 52

Patch Management Finally Gets Some Respect Nothing makes a security buyer flinch faster than a machine carrying a known vulnerability for weeks, and Action1 has plainly found that nerve. The Houston-based autonomous endpoint management company says it was the fastest-growing endpoint management vendor on Deloitte's 2026 Technology Fast 500 for the second consecutive year,...

Continue Reading
Alphabet Lawsuit Puts Gemini Delays Under a Microscope

Updated Category News Views 99

July’s twin punches to Alphabet shares were not the sort of wobble investors can casually shrug off. First came a report on July 16 that Google was months behind on Gemini 3.5 Pro, its flagship AI model, after disappointing results from updated training data. Then came the harder financial reality a week later: a much larger 2026 capital-spending plan, negative...

Continue Reading
AIC Hotel Group's 11 Awards Test Resort Market Reach

Updated Category News Views 89

Eleven Trophies, Four Properties, One Useful Signal Hospitality awards can be a lot of polished brass and very little cash flow, but this batch is substantial enough to deserve a hard look. AIC Hotel Group collected 11 honors spanning Condé Nast Traveler's 2026 Readers' Choice Awards, Travel Weekly's 2026 Magellan Awards, and Good Housekeeping's 2027 Travel Awards. The...

Continue Reading

Top 5 Most Recently Viewed Articles

Jyske Realkredit A/S Announces New Bond Listing Details

Updated Category News Views 192

Key Announcement about New Bond Listings On August 20, Jyske Realkredit A/S is set to introduce new bonds to the market. This announcement signals a pivotal moment for investors and the financial community alike. The company is preparing to list a novel type of Covered Bond (SDO) and a Mortgage Bond (RO), which could have significant implications for the current market...

Continue Reading
Maze Therapeutics Engages Investors at Major BioConnect Event

Updated Category News Views 168

Maze Therapeutics Engages Investors at a Major Event Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company, is making waves in the healthcare industry with its innovative approach to developing small molecule precision medicines. Their focus on addressing renal, metabolic, and cardiovascular diseases underscores the company's commitment to...

Continue Reading
Iterum Therapeutics Successfully Completes $5 Million Offering

Updated Category News Views 161

Iterum Therapeutics Completes Significant Offering Iterum Therapeutics plc (NASDAQ: ITRM), a biopharmaceutical company dedicated to creating innovative solutions against multi-drug resistant pathogens, has officially announced the successful closure of its recent direct offering. This strategic fundraising effort resulted in the sale of 5,555,556 ordinary shares, or the...

Continue Reading
Shopify Achieves Unprecedented Milestone with $14.6 Billion Sales

Updated Category News Views 210

Shopify's Impressive Holiday Sales Growth Shopify Inc. (NASDAQ: SHOP) has recently announced a phenomenal achievement, showcasing that merchants on its platform generated a staggering $14.6 billion in sales during the holiday shopping weekend. This impressive figure marks a magnificent 27% increase compared to the previous year, with approximately 81 million customers...

Continue Reading
Hotel Okura and AWC Set to Launch Unique Ryokan Hotels

Updated Category News Views 305

Hotel Okura and AWC Announce New Ryokan-Style Hotels In an exciting development for Thailand's hospitality sector, Hotel Okura Co., Ltd., a leading global player in the Japanese hotel industry, has partnered with Asset World Corporation (AWC). This collaboration will bring two new ryokan-style hotels to Chiang Mai and Bangkok, both slated to open by the year 2028. This...

Continue Reading